ADVERTISEMENT
ADVERTISEMENT
An illustration of circulating tumor cells surrounded by red blood cells.
Monitoring Multiple Myeloma Progression through Sequencing
Irene Ghobrial sequences circulating tumor cells in blood samples to genomically profile patients with multiple myeloma.
Monitoring Multiple Myeloma Progression through Sequencing
Monitoring Multiple Myeloma Progression through Sequencing

Irene Ghobrial sequences circulating tumor cells in blood samples to genomically profile patients with multiple myeloma.

Irene Ghobrial sequences circulating tumor cells in blood samples to genomically profile patients with multiple myeloma.

myeloma

Sartorius
Understanding the Blood Cancer Genomic Landscape 
The Scientist | Dec 13, 2022 | 1 min read
Information about the genomic and immunological characteristics of blood cancers is helping scientists discover and develop new immunotherapies.
CRISPR-Edited T Cells Used in Cancer Patients for the First Time in the US
Emily Makowski | Nov 6, 2019 | 2 min read
The initial findings from a small clinical trial of patients with multiple myeloma or sarcoma suggest that gene-edited immunotherapy is safe.
Genetic Sequencing Uncovers New Options for Multiple Myeloma Patients
Shawna Williams | Nov 1, 2018 | 5 min read
A small pilot study suggests the approach can identify effective treatments already approved for other cancers.
CRISPR Trial for Cancer Patients Proposed
Katarina Zimmer | Jan 18, 2018 | 1 min read
US researchers could become the first outside China to use the gene-editing technique in the clinic. 
ADVERTISEMENT